TLRY Summary

  1. NASDAQ
  2. >
  3. TLRY
TickerTLRY
DescriptionTILRAY INC
Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment sales consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment sales consist of hemp seed, hemp foods, board spectrum hemp extract containing CBD which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada.
ExchangeNASDAQ
TypeStock
SectorHealthcare
Employees1,646
Next Earnings DateNovember 17th, 2020
IV80.060906%
IV Percentile20th
IV Rank5.62%
IV Skew-44.569460
IV Skew Percentile6th
IV Skew SentimentBullish
Option Volume32,297
Volume7,354,738
Price$7.17
Previous Close$7.05
52-Week High$42.17
52-Week Low$2.43
50-Day Moving Avg.$7.95
200-Day Moving Avg.$12.36
10-Day Avg. Volume8,727,826
20-Day Avg. Volume7,332,762
30-Day Avg. Volume6,974,256
3-Month Avg. Volume9,608,019
EPS-$4.62
Outstanding Shares111,426,000
Float95,473,028
Market Capitalization$768,838,200
CurrencyUSD
UpdatedAugust 14th, 2020